MWNA
MLNT

Marshall Wace North America’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Marshall Wace North America’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,423
Closed -$48K – 1739
2018
Q3 		$48K Buy
+2,423
New +$48K ﹤0.01% 881